formaldehyde and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

formaldehyde has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, T; Deyama, S; Kaneda, K; Minami, M; Mori, S; Sugano, Y; Yoshioka, M1

Other Studies

1 other study(ies) available for formaldehyde and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

ArticleYear
Activation of the NMDA receptor-neuronal nitric oxide synthase pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain.
    Neuropharmacology, 2017, 05-15, Volume: 118

    Topics: Animals; Conditioning, Operant; Cyclic N-Oxides; Disease Models, Animal; Excitatory Postsynaptic Potentials; Formaldehyde; Free Radical Scavengers; Hydroxylamines; Imidazoles; Male; Membrane Potentials; Neurons; Nitric Oxide Synthase Type I; Nitro Compounds; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Septal Nuclei; Signal Transduction

2017